The Executive Vice Chairman* of Chubb (NYSE: CB) is Selling Shares (Analyst Ratings)
Today, the Executive Vice Chairman* of Chubb (CB), John Keogh, sold shares of CB for $4.05M. Following John Keogh’s last CB Sell transaction on October 12, 2018, the stock climbed by 31.6%. In addition to John Keogh, one other CB executive reported Sell trades in the last month.
Schmitt Industries Inc (SMIT) CEO Michael R. Zapata Bought $401,232 of Shares (Guru Focus)
CEO of Schmitt Industries Inc., Michael R. Zapata bought 123,456 shares of SMIT on 12/17/2019 at an average price of $3.25 a share. The total cost of this purchase was $401,232. Schmitt Industries Inc designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the machine tool industry, particularly for grinding machines. Schmitt Industries Inc has a market cap of $15.020 million; its shares were traded at around $3.66 with and P/S ratio of 1.08. GuruFocus has detected 3 severe warning signs with Schmitt Industries Inc.
Latest Plot Twist: Pension Fund Sues Xerox Majority Shareholder Carl Icahn for Buying HP Stock (PiWorld.com)
With the M&A battle still waging between Xerox Holdings and HP Inc., majority Xerox shareholder and activist investor Carl Icahn, and an investment vehicle he controls, are being sued by a pension fund that is also a shareholder in Xerox. According to Bloomberg, the Miami Firefighters and Pension Fund filed a lawsuit in Manhattan on Dec. 13, claiming that Xerox board member Icahn, Icahn Capital, and High River Limited Partnership, breached their fiduciary duties when they acquired $1.2 billion worth of HP stock. The suit alleges that Icahn knew Xerox was contemplating an unsolicited $33.5 billion stock-and-cash offer to acquire HP — a proposal that ultimately valued HP stock at a premium of $22 per share.
50 Ways to Leave Your Hedge Fund (Bloomberg)
Quitting is never easy — especially for the alpha types who make up the $3 trillion hedge fund industry. Yet some of the best-known founders have thrown in the towel this year after fortune-making decades in the business.These traders all had their own reasons to hang it up. But there were some common factors behind the decisions: the challenge of competing with an ever-rising stock market, the difficulty of raising enough assets and, for many, the march of time. As 63-year-old Jonathan Kolatch told investors earlier this month when announcing his retirement: “If I don’t step away now, it’s not clear I will ever get away from my desk.”
What Did This CEO Just Do with Personal Shares of Continental Resources (NYSE: CLR)? (Analyst Ratings)
Yesterday, the CEO & Chairman of Continental Resources (CLR), Harold Hamm, sold shares of CLR for $60.27M. This is Hamm’s first Sell trade following 14 Buy transactions.
Dicerna Pharmaceuticals Inc (DRNA) CEO Douglas Fambrough Sold $3.6 million of Shares (Guru Focus)
CEO of Dicerna Pharmaceuticals Inc., Douglas Fambrough, sold 139,021 shares of DRNA on 12/18/2019 at an average price of $26 a share. The total sale was $3.6 million. Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.
